Fig. 6From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathwaySurvival analysis. a The survival duration is significantly higher in the K562/si-FAM168A mice compared to K562/Control mice. b The near death body weight in the K562/Control and K562/si-FAM168A mice was significantly lowers compared to the PBS Control mice. Error bars indicate the mean ± SD. **p < 0.01Back to article page